Relation between central cerebral atrophy, memory defects and prolactin secretion

Area of Science:

• Neurology
• Neuroendocrinology
• Cognitive Neuroscience

Background:

• Central cerebral atrophy can impact cognitive functions, particularly memory.
• Prolactin, a hormone, is produced in the pituitary gland and its levels can be altered in various neurological conditions.
• The relationship between prolactin levels and central cerebral atrophy or memory deficits requires further investigation.

Purpose of the Study:

• To investigate the correlation between prolactin concentrations in cerebrospinal fluid (CSF) and serum with central cerebral atrophy and memory dysfunction in neurological patients.
• To determine if prolactin levels can serve as a biomarker for central cerebral atrophy or memory impairments.

Main Methods:

• Measurement of prolactin concentrations in CSF and serum from 26 neurological patients with or without central cerebral atrophy.
• Performance of neuropsychological memory tests on the same patient cohort.
• Comparison of prolactin levels between patients with and without central cerebral atrophy and/or memory defects, using 28 neurological patients with peripheral lesions as controls.

Main Results:

• Patients with central cerebral atrophy exhibited a significant decline in recall capacity but maintained overall intellectual performance.
• No significant differences were observed in CSF and serum prolactin levels between patients with and without central cerebral atrophy or memory deficits.
• Prolactin levels did not correlate with the presence or severity of central cerebral atrophy or memory dysfunctions.

Conclusions:

• Serum and CSF prolactin levels do not appear to be reliable indicators of central cerebral atrophy or memory dysfunction in the studied neurological patient population.
• The minor degree of neuronal atrophy around the third ventricle in these patients may explain the lack of correlation with prolactin levels.
• Further research with different patient cohorts or more advanced atrophy may be needed to fully elucidate the role of prolactin in neurological disorders.